Transforming growth factor β1 gene polymorphism in patients with systemic sclerosis

Journal of Rheumatology

Volumn 30, Issue 7, 2003, Pages 1520-1523

  Sugiura, Yoshiki ^b   Banno, Shogo ^a   Matsumoto, Yoshifuji ^b   Niimi, Takashi ^b   Yoshinouchi, Takeo ^b   Hayami, Yoshihito ^b   Naniwa, Taio ^b   Ueda, Ryuzo ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

DNA polymorphism; Systemic sclerosis; Transforming growth factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC SCLEROSIS;

ADULT; DNA; DNA FINGERPRINTING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTORS;

EID: 0038505528     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Corrin B, Butcher D, McAnulty BJ, Dubois RM, Laurent GJ, Harrison NK. Immunohistochemical localization of transforming growth factor-β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 1994;24:145-50.
2. Querfeld C, Eckes B, Huerkamp C, Krieg T, Sollberg S. Expression of TGF-β1,-β2 and -β3 in localized and systemic scleroderma. J Dermatol Sci 1999;21:13-22.
3. Ihn H, Yamane K, Kubo M, Tamaki K. Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts. Arthritis Rheum 2001;44:474-80.
4. Susol E, Rands AL, Herrick A, et al. Association of markers for TGFβ3, TGFβ2, and TIMP1 with systemic sclerosis. Rheumatology 2000;39:1332-6.
5. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis 2002;61:678-81.
6. LeRoy C, Medsger Jr TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
7. Wood NAP, Thomson SC, Smith RM, Bidwell JL. Identification of human TGF-β1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 2000;234:117-22.
8. Awad MR, El-Gamel Ahmed, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene. Association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;8:1014-20.
9. Grainger DJ, Heathcote K, Chiano M. Genetic control of the circulating concentration of transforming growth factor typeβ1. Hum Mol Genetics 1999;8:93-7.
10. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. Hypertension 1996;28:881-7.
11. Yokota M, Ichihara S, Lin T-L, Nakashima N, Yamada Y. Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-7.
12. Zhou X, Tan FK, Stivers DN, Arnett FC. Microsatellites and intragenic polymorphisms of transforming growth factor β and platelet-derived growth factor and their receptor genes in native Americans with systemic sclerosis (scleroderma). Arthritis Rheum 2000;43:1068-73.
13. Yamada Y, Miyauchi A, Takagi Y, Tanaka M, Mizuno M, Harada A. Association of C-509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β 1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med 2001;79:149-56.
14. Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000;97:3479-88.
15. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV. TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 2000; 55:459-62.